1. Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med. 2020;28(suppl 1):6-17.
2. Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol. 2021;236(1):49-54. [
DOI:10.1002/jcp.29868] [
PMID] [
PMCID]
3. Arefinia N, Ghoreshi Z-a-S, Alipour AH, Reza Molaei H, Samie M, Sarvari J. Gastrointestinal Manifestations in Patients Infected with SARS-CoV-2. Iran J Med Microbiol. 2022;16(4):271-81. [
DOI:10.30699/ijmm.16.4.271]
4. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395(10231):1225-8. [
DOI:10.1016/S0140-6736(20)30627-9] [
PMID]
5. Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. [
DOI:10.1111/apa.15270] [
PMID] [
PMCID]
6. Sharifi Luyeh M, Ashraf A, Souri Z, Mojtahedi A, Ansar MM. Clinical Features and Predictors associated with Mortality in Non-Survived Patients of COVID-19 in a Referral Hospital in Rasht, North of Iran. Iran J Med Microbiol. 2022;16(3):259-66. [
DOI:10.30699/ijmm.16.3.259]
7. Esposito S, Principi N. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Paediatr Drugs. 2021(2):119-29. [
DOI:10.1007/s40272-020-00435-x] [
PMCID]
8. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8. [
DOI:10.1016/S0140-6736(20)31103-X] [
PMID]
9. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10(6):537-40. [
DOI:10.1542/hpeds.2020-0123] [
PMID]
10. Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract. 2020;40:101214. [
DOI:10.1016/j.ctcp.2020.101214] [
PMID] [
PMCID]
11. Torabi R, Ranjbar R, Halaji M, Heiat M. Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review. Mol Cell Probes. 2020;53:101636. [
DOI:10.1016/j.mcp.2020.101636] [
PMID] [
PMCID]
12. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;45(6):e20200702. [
DOI:10.1542/peds.2020-0702] [
PMID]
13. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370-1. [
DOI:10.1056/NEJMc2003717] [
PMID] [
PMCID]
14. Shulman ST, Rowley AH. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015;11(8):475. [
DOI:10.1038/nrrheum.2015.54] [
PMID]
15. Turnier JL, Anderson MS, Heizer HR, Jone P-N, Glodé MP, Dominguez SR. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136(3):e609-e4. [
DOI:10.1542/peds.2015-0950] [
PMID]
16. Cazzaniga M, Baselli LA, Cimaz R, Guez SS, Pinzani R, Dellepiane RM. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association. Front Pediatr. 2020;8:398. [
DOI:10.3389/fped.2020.00398] [
PMID] [
PMCID]
17. Akca UK, Kesici S, Ozsurekci Y, Aykan HH, Batu ED, Atalay E, et al. Kawasaki-like disease in children with COVID-19. Rheumatol Int. 2020;40(12):2105-15. [
DOI:10.1007/s00296-020-04701-6] [
PMID] [
PMCID]